{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Morales-Marroquin E"],"funding":["NIMHD NIH HHS"],"pagination":["1539-1545"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12292007"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["32(5)"],"pubmed_abstract":["<h4>Purpose</h4>Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.<h4>Methods</h4>Retrospective analysis of 2015-2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher's exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.<h4>Results</h4>The use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26-38 min).<h4>Conclusion</h4>Robotic MBS shows higher intervention and readmission even after controlling for cofounding variables."],"journal":["Obesity surgery"],"pubmed_title":["Five Year Trends in the Utilization of Robotic Bariatric Surgery Procedures, United States 2015-2019."],"pmcid":["PMC12292007"],"funding_grant_id":["R01 MD011686"],"pubmed_authors":["Qureshi FG","Khatiwada S","Kukreja S","Messiah SE","Schneider B","Xie L","de la Cruz-Munoz N","Morales-Marroquin E"],"additional_accession":[]},"is_claimable":false,"name":"Five Year Trends in the Utilization of Robotic Bariatric Surgery Procedures, United States 2015-2019.","description":"<h4>Purpose</h4>Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.<h4>Methods</h4>Retrospective analysis of 2015-2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher's exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.<h4>Results</h4>The use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26-38 min).<h4>Conclusion</h4>Robotic MBS shows higher intervention and readmission even after controlling for cofounding variables.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 May","modification":"2026-03-15T17:00:13.109Z","creation":"2025-08-13T03:04:15.714Z"},"accession":"S-EPMC12292007","cross_references":{"pubmed":["35169953"],"doi":["10.1007/s11695-022-05964-7"]}}